Table 2 Results from PAMM regression models for inpatient outcomes only, stratified by length of risk window

From: High risk for life-threatening adverse events of fluoroquinolones in young adults: a large German population-based cohort study

Outcome of interest	aHR [95% CI]
	Risk window (follow-up period)
	≤ *30 days*	≤ *60 days*	≤ *92 days*	≤ *365 days*
Aortic events	1.40 [1.27;1.55]	1.32 [1.22;1.43]	1.30 [1.21;1.39]	1.17 [1.12;1.22]
Cardiac events	1.14 [1.11;1.17]	1.14 [1.11;1.16]	1.13 [1.11;1.15]	1.09 [1.08;1.10]
Hepatic events	1.69 [1.54;1.86]	1.67 [1.55;1.80]	1.61 [1.51;1.72]	1.41 [1.35;1.46]
All-cause mortality	1.24 [1.22;1.26]	1.26 [1.25;1.28]	1.27 [1.26;1.28]	1.23 [1.23;1.24]

adjusted hazard ratio (aHR) [95% confidence interval (CI) [lower confidence level; upper confidence level] | aortic events = aortic aneurysm/-dissection | cardiac events = cardiac arrhythmia/sudden cardiac death |hepatic events = acute toxic liver injury/acute liver failure

Back to article page

ISSN: 1741-7015

Contact us

General enquiries: journalsubmissions@springernature.com